Last updated on August 2019

Study of Pembrolizumab (MK-3475) in Adults With Recurrent/Metastatic Cutaneous Squamous Cell Carcinoma (cSCC) or Locally Advanced Unresectable cSCC (MK-3475-629/KEYNOTE-629)


Find a site near you

Start Over

Yale University ( Site 0365)

New Haven, CT United States
  Connect »